Sandoz AG Switzerland is a member of Novartis Group and operates in the field of research, development, distribution and sale of pharmaceutical products, according to the antitrust body.
UK-based GSK is a global pharmaceutical company listed on the London Stock Exchange, and with a secondary listing on the New York Stock Exchange. The company operates in the field of research, development, distribution and sale of pharmaceutical products.
In Romania, the two groups are active in the field of pharmaceutical product sale.
The sale activity to be acquired by Sandoz AG includes the brands Zinnat, Zinacef and Fortum.
The antitrust watchdog undertakes to assess the economic concentration operation in terms of its compatibility with the normal competitive environment and to issue a decision under the legal deadlines.